Preclinical assessments of safety and tumorigenicity of very high doses of allogeneic human umbilical cord mesenchymal stem cells.

In Vitro Cell Dev Biol Anim · 2024 · PMC11014873 · PMID 38421574

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

a decreasing trendno p-value reported

4 a , b ), we observed that all Cytopeutics® hUC-MSCs-treated groups displayed a decreasing trend in plasma level of TNF-α and IL-6 in dose-dependent manner at 14 d after cell injection.

also in 47,180 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.